Author

Alessandro Sinopoli

ORCID 0000-0001-7993-4268Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Alessandro Sinopoli1 paper

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alvin HsuiD· 1 shared Amélie WiederkehriD· 1 shared André LieberiD· 1 shared Anna CamusiD· 1 shared Chang Long LiiD· 1 shared Christopher DivsalariD· 1 shared David R. LiuiD· 1 shared Diego CalabreseiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alvin HsuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintJul 8, 2026

CD117 epitope-shielded hematopoietic stem cell transplantation with toxin-free conditioning and in vivo selection ameliorates β-thalassemia model

Romina Marone, Rosalba Lepore, Kiriaki Paschoudi…·Lukas T. Jeker

This paper demonstrates a method using CD117-blocking antibody and epitope-engineered HSPCs to treat β-thalassemia without myeloablative conditioning.

DOI 10.64898/2026.07.07.736903

𝕏 PostBluesky